Position
Parallel Advisors, LLC in Biomarin Pharmaceutical Inc
Back to the book · All holders of BMRN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$3.88K$59.43 → $56.49
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.32K | $78.4K | — | — | — | 0.0% |
| Q1 2026 | 1.77K | $99.9K | $56.49 | −$3.88K | $25.3K | 0.0% |